Reducing Malaria Transmission with Artemisinin Combination Therapies
Author Information
Author(s): Lucy C Okell, Chris J Drakeley, Azra C Ghani, Teun Bousema, Colin J Sutherland
Primary Institution: London School of Hygiene & Tropical Medicine
Hypothesis
Does treatment with artemisinin combination therapies (ACT) reduce malaria transmission compared to non-artemisinin treatments?
Conclusion
ACT treatment significantly reduces the infectiousness of patients with uncomplicated falciparum malaria compared to previous first-line treatments.
Supporting Evidence
- ACT treatment was associated with a significant reduction in gametocytaemia.
- Patients treated with ACT had lower transmission rates to mosquitoes.
- Parasitological treatment failure did not account for the differences observed.
- ACT reduced the area under the curve of gametocyte density significantly.
- Presence of pre-treatment gametocytes reduced the effectiveness of ACT.
Takeaway
Using a special malaria treatment called ACT helps sick people not spread the disease to mosquitoes, which is good for everyone.
Methodology
Data from six randomized trials were pooled and analyzed using multivariable regression to assess the impact of ACT on malaria transmission.
Potential Biases
Differences in treatment regimens and study settings may introduce variability in results.
Limitations
The study may not fully account for the impact of submicroscopic gametocytaemia on transmission.
Participant Demographics
Patients with uncomplicated microscopy-confirmed P. falciparum malaria, aged around 5 years.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI 0.16–0.26
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website